Micromobility-Linked Injuries Comprise 6.9 Percent of Trauma Admissions

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 15, 2026.

via HealthDay

WEDNESDAY, April 15, 2026 -- From 2018 to 2023, micromobility-related injuries accounted for 6.9 percent of all trauma admissions, according to a study published online April 15 in Neurosurgery.

Hannah Weiss, M.D., from NYU Langone Health in New York City, and colleagues performed a retrospective review to examine micromobility-related injuries over time at a level 1 trauma center during a five-year period (2018 to 2023). The cohort included riders of electric or mechanical bikes and scooters and pedestrians who were injured by these devices.

Nine hundred fourteen patients presented with micromobility-related injuries, accounting for 6.9 percent of all trauma admissions. The researchers found that over time, there was an increase in annual case volume and electric device involvement. Collision with a motor vehicle was the most common mechanism (49.9 percent). Overall, 68.7 percent of patients required admission and 30.2 percent required intensive care. The median length of stay was three days. Half of the patients underwent surgical intervention or procedure; there was overall mortality of 1.2 percent. Only 31.7 percent used helmets. The most severe outcomes were experienced by pedestrians, especially when struck by electric devices. There was a clustering of injuries during evening hours.

"The data point to actionable solutions -- helmet use, safer bike lane design, and enforcement -- that could prevent many of these injuries and better protect both riders and pedestrians, who in our study often sustained even more severe brain injuries than riders themselves," Weiss said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-16 02:10

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords